FLT3 and acute myeloid leukemia: Apart from FLT3 mutants, most patients usually fall into this group (an umbrella category) by virtue of not fulfilling criteria that identify specific entities (e.g., core-binding factor AML, TP53 mutations, complex karyotypes) with well-recognized prognostic significance.